Intracellular peptides in SARS-CoV-2-infected patients.

Microbiology Public health Virology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
15 Sep 2023
Historique:
received: 10 03 2023
revised: 29 05 2023
accepted: 01 08 2023
medline: 28 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: epublish

Résumé

Intracellular peptides (InPeps) generated by the orchestrated action of the proteasome and intracellular peptidases have biological and pharmacological significance. Here, human plasma relative concentration of specific InPeps was compared between 175 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and 45 SARS-CoV-2 non-infected patients; 2,466 unique peptides were identified, of which 67% were InPeps. The results revealed differences of a specific group of peptides in human plasma comparing non-infected individuals to patients infected by SARS-CoV-2, following the results of the semi-quantitative analyses by isotope-labeled electrospray mass spectrometry. The protein-protein interactions networks enriched pathways, drawn by genes encoding the proteins from which the peptides originated, revealed the presence of the coronavirus disease/COVID-19 network solely in the group of patients fatally infected by SARS-CoV-2. Thus, modulation of the relative plasma levels of specific InPeps could be employed as a predictive tool for disease outcome.

Identifiants

pubmed: 37636076
doi: 10.1016/j.isci.2023.107542
pii: S2589-0042(23)01619-X
pmc: PMC10448160
doi:

Types de publication

Journal Article

Langues

eng

Pagination

107542

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

All authors declare no conflict of interest.

Références

Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Clin Proteomics. 2018 Dec 01;15:39
pubmed: 30519149
Bioinformatics. 2012 Jan 15;28(2):288-9
pubmed: 22113085
Nat Commun. 2022 Feb 16;13(1):888
pubmed: 35173144
EClinicalMedicine. 2021 Jun;36:100883
pubmed: 33969282
Viruses. 2022 Apr 25;14(5):
pubmed: 35632633
Nat Commun. 2019 Mar 18;10(1):1240
pubmed: 30886144
Front Genet. 2019 Sep 25;10:858
pubmed: 31608109
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Signal Transduct Target Ther. 2023 Feb 27;8(1):84
pubmed: 36849525
EBioMedicine. 2022 Nov;85:104293
pubmed: 36182629
Eur J Neurol. 2023 May;30(5):1272-1280
pubmed: 36807419
Thromb Res. 1994 Jul 15;75(2):195-202
pubmed: 7974393
Mol Biosyst. 2012 Jan;8(1):268-81
pubmed: 21909575
Biomolecules. 2019 Apr 16;9(4):
pubmed: 30995799
J Clin Invest. 2004 Jul;114(1):104-11
pubmed: 15232617
Sci Rep. 2021 Jul 27;11(1):15223
pubmed: 34315957
Sci Signal. 2021 Jan 12;14(665):
pubmed: 33436497
ACS Cent Sci. 2021 Jan 27;7(1):156-163
pubmed: 33527085
Science. 1997 Dec 19;278(5346):2075-80
pubmed: 9405336
Nat Rev Drug Discov. 2003 Sep;2(9):703-16
pubmed: 12951577
Sci Rep. 2022 Jan 24;12(1):1212
pubmed: 35075175
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
J Proteomics. 2017 Jan 16;151:74-82
pubmed: 27523479
AAPS J. 2010 Dec;12(4):608-16
pubmed: 20665142
Nat Immunol. 2022 Feb;23(2):186-193
pubmed: 35105982
Nature. 2021 Jun;594(7862):240-245
pubmed: 33979833
Trends Pharmacol Sci. 2022 Mar;43(3):234-248
pubmed: 34911657
Lancet Digit Health. 2022 Oct;4(10):e727-e737
pubmed: 36057526
Bioinformatics. 2015 Dec 15;31(24):3997-9
pubmed: 26315911
Biomed Res Int. 2021 Jul 6;2021:9939134
pubmed: 34307679
Cell. 2021 Apr 1;184(7):1895-1913.e19
pubmed: 33657410
Circulation. 1997 Mar 4;95(5):1115-8
pubmed: 9054837
J Infect. 2020 Sep;81(3):e41-e43
pubmed: 32603675
Pharmaceutics. 2021 Sep 02;13(9):
pubmed: 34575464
EMBO J. 2005 Apr 20;24(8):1634-43
pubmed: 15791205
Bioorg Med Chem. 2018 Jun 1;26(10):2700-2707
pubmed: 28720325
J Proteomics. 2017 Jan 16;151:24-32
pubmed: 27371349
Mol Cell Proteomics. 2017 Dec;16(12):2055-2068
pubmed: 28982716
Int J Mol Sci. 2018 Mar 07;19(3):
pubmed: 29518939
J Mol Cell Cardiol. 1999 Jan;31(1):51-60
pubmed: 10072715
Int J Mol Sci. 2021 Aug 17;22(16):
pubmed: 34445532
J Neurochem. 2010 May;113(4):871-80
pubmed: 20202081
Cell. 2011 Mar 18;144(6):986-98
pubmed: 21414488
Drug Discov Today. 2021 Jun;26(6):1521-1531
pubmed: 33524603
Cell Death Discov. 2021 Nov 12;7(1):351
pubmed: 34772908
Int Rev Neurobiol. 2022;165:63-89
pubmed: 36208907
Comput Struct Biotechnol J. 2021;19:1838-1847
pubmed: 33758649
Front Immunol. 2020 Dec 10;11:598444
pubmed: 33362782
J Infect. 2020 Aug;81(2):318-356
pubmed: 32283163
Sci Rep. 2019 May 21;9(1):7635
pubmed: 31114012
Nature. 2021 Jan;589(7840):125-130
pubmed: 32906143
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990
Biomolecules. 2020 Feb 17;10(2):
pubmed: 32079362
Blood. 2020 Sep 10;136(11):1317-1329
pubmed: 32573711
Nucleic Acids Res. 2019 Jan 8;47(D1):D442-D450
pubmed: 30395289
Mol Cell. 2020 Oct 1;80(1):164-174.e4
pubmed: 32877642
J Biol Chem. 2014 Jun 13;289(24):16711-26
pubmed: 24764300
Bioinformatics. 2007 Apr 15;23(8):980-7
pubmed: 17303618
Mol Cell. 2016 Oct 6;64(1):12-23
pubmed: 27716480
Nat Commun. 2021 Nov 19;12(1):6761
pubmed: 34799561
Front Cardiovasc Med. 2023 Jan 06;9:1054690
pubmed: 36684608
Br J Nutr. 2000 Nov;84 Suppl 1:S99-102
pubmed: 11242453
Nat Cancer. 2023 May;4(5):629-647
pubmed: 37217651
Nucleic Acids Res. 2022 Jan 7;50(D1):D497-D508
pubmed: 34718738
Mol Biol Rep. 2022 Mar;49(3):2303-2309
pubmed: 35076845
PLoS One. 2016 Jan 27;11(1):e0147297
pubmed: 26815288
Bioinformatics. 2012 Nov 1;28(21):2856-7
pubmed: 22954629
Immunity. 2002 Sep;17(3):251-63
pubmed: 12354379
Reumatol Clin (Engl Ed). 2020 Nov - Dec;16(6):455-461
pubmed: 30594439
Signal Transduct Target Ther. 2021 Mar 6;6(1):110
pubmed: 33677468
Nucleic Acids Res. 2020 Jan 8;48(D1):D1145-D1152
pubmed: 31686107
Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:457-476
pubmed: 31479618
Clin Transl Immunology. 2021 Mar 18;10(3):e1240
pubmed: 33747508
PLoS One. 2016 Sep 29;11(9):e0163312
pubmed: 27685651
Proteomics Clin Appl. 2018 Sep;12(5):e1700163
pubmed: 29611317
Genes Dev. 2000 May 1;14(9):1027-47
pubmed: 10809663
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945

Auteurs

Luiz Felipe Martucci (LF)

Department of Pharmacology, Biomedical Sciences Institute, São Paulo 05508-000, Brazil.

Rosangela A S Eichler (RAS)

Department of Pharmacology, Biomedical Sciences Institute, São Paulo 05508-000, Brazil.

Renée N O Silva (RNO)

Department of Pharmacology, Biomedical Sciences Institute, São Paulo 05508-000, Brazil.

Tiago J Costa (TJ)

Department of Pharmacology, Ribeirao Preto Medical School, Ribeirão Preto 14049-900, Brazil.

Rita C Tostes (RC)

Department of Pharmacology, Ribeirao Preto Medical School, Ribeirão Preto 14049-900, Brazil.

Geraldo F Busatto (GF)

Department of Psichiatry, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.

Marilia C L Seelaender (MCL)

Department of Surgery, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.

Alberto J S Duarte (AJS)

Department of Patology, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.

Heraldo P Souza (HP)

Department of Internal Medicine, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.

Emer S Ferro (ES)

Department of Pharmacology, Biomedical Sciences Institute, São Paulo 05508-000, Brazil.
Department of Patology, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.
Department of Internal Medicine, Medical School and Hospital das Clínicas, University of São Paulo, 01246-903 SP, Brazil.

Classifications MeSH